- Home
- CNMD
CNMD
CONMED Corporation
as 08-29-2025 2:31pm EST
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | LARGO |
| Market Cap: | 1.7B | IPO Year: | 1987 |
| Target Price: | $59.80 | AVG Volume (30 days): | 471.6K |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.54 | EPS Growth: | 12.82 |
| 52 Week Low/High: | $46.00 - $78.19 | Next Earning Date: | 07-30-2025 |
| Revenue: | $1,326,244,000 | Revenue Growth: | 3.94% |
| Revenue Growth (this year): | 6.73% | Revenue Growth (next year): | 5.45% |
Latest CONMED Corporation News
CNMD Breaking Stock News: Dive into CNMD Ticker-Specific Updates for Smart Investing
Zacks
7 days ago
Here's Why Conmed (CNMD) is a Strong Growth Stock
Simply Wall St.
2 months ago
Is Now An Opportune Moment To Examine CONMED Corporation (NYSE:CNMD)?
StockStory
2 months ago
The 5 Most Interesting Analyst Questions From CONMED’s Q1 Earnings Call
Argus Research
2 months ago
CNMD: Raising target price to $58.00
Zacks
2 months ago
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
StockStory
2 months ago
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
MT Newswires
3 months ago
Conmed Shares Fall After Needham Downgrade
MT Newswires
3 months ago
Needham Downgrades CONMED to Hold From Buy, Removes $61 Price Target
Compare CNMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CNMD CONMED Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.